Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/12/2025

Management of CO2 Narcosis

Immediate Oxygen Management

  • The British Thoracic Society recommends starting with 24% Venturi mask at 2-3 L/min or 28% Venturi mask at 4 L/min, targeting SpO2 88-92% 1, 4
  • Limit nasal cannulae flow to 1-2 L/min initially to avoid worsening hypercapnia 1, 4
  • Obtain arterial blood gases within 30 minutes of oxygen initiation and repeat at 30-60 minute intervals to monitor for rising PaCO2 or falling pH 1, 4

Urgent Diagnostic Workup

  • The American Thoracic Society suggests suspecting amyotrophic lateral sclerosis (ALS), muscular dystrophy, or myasthenia gravis in patients with CO2 narcosis without known COPD or infection 3
  • Measure vital capacity (VC) - if <1 L with respiratory rate >20, NIV is indicated even if normocapnic 2, 3
  • Assess for kyphoscoliosis or severe obesity (obesity-hypoventilation syndrome) as potential causes of chronic hypercapnia 2, 3, 6

Ventilatory Support Decision Algorithm

  • Initiate NIV if pH <7.35 with elevated PaCO2 after 30 minutes of controlled oxygen and standard medical therapy 7, 1, 2
  • For neuromuscular disease/chest wall deformity, do not wait for acidosis to develop - any elevation in PaCO2 in a breathless patient warrants NIV 2, 3

NIV Settings

  • Start with low pressure support: IPAP-EPAP difference of 8-12 cm H2O for neuromuscular disease 2, 3
  • Set inspiratory/expiratory ratio at 1:1 initially 2, 3
  • Target oxygenation: SpO2 88-92% during NIV 1, 8

Pharmacological Adjuncts

  • Consider doxapram infusion if pH <7.26 and/or severe hypercapnia to bridge 24-36 hours until underlying cause controlled 7
  • Use air-driven nebulizers with supplemental oxygen via nasal cannulae at 2-6 L/min to maintain SpO2 88-92% 9, 5

Invasive Mechanical Ventilation Considerations

  • Factors favoring intubation and IMV include first episode of respiratory failure, demonstrable remedial cause, and acceptable baseline quality of life 7
  • Factors against IMV include poor baseline quality of life despite maximal therapy and severe comorbidities 7

Monitoring Parameters

  • Monitor arterial blood gases every 30-60 minutes until stable, then every 4-6 hours 1, 4
  • Use continuous pulse oximetry targeting 88-92% 1, 4
  • Monitor respiratory rate and work of breathing 1
  • Assess mental status (Glasgow Coma Scale) 7